Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers, Special Interest Project Competitive Supplements (SIPS) (U48 Panels N, O and P), RFA-DP09-101SUPP09, Initial Review, 40822 [E9-19293]
Download as PDF
<![CDATA[
40822
Federal Register / Vol. 74, No. 155 / Thursday, August 13, 2009 / Notices
is to determine eligibility for the 340B
program. This information is received
and verified according to 340B
requirements and entered into the 340B
database. Accurate records are critical to
implementation of the 340B legislation
especially to prevent diversion and
duplicate discounts. To maintain
accurate records, the OPA requests
entities to submit modifications to any
administrative information that they
submitted when initially enrolling into
the program. The burden requirement
for these processes is minimal.
Contract Pharmacy Self-Certification
In order to ensure that drug
manufacturers and drug wholesalers
recognize contract pharmacy
Number of
respondents
Reporting requirement
Responses
per
respondent
arrangements, covered entities that elect
to utilize a contract pharmacy are
required to submit to OPA a selfcertification form similar to the
registration form that they have signed
an agreement with the contract
pharmacy.
The Estimates of annualized burden
are as follows:
Total
responses
Hours per
response
Total burden
hours
DSH & Children’s Hospital Enrollment, Additions & Recertifications
340B Program Registrations & Certifications for Disproportionate Share Hospitals ......................................
340B Program Registrations & Certifications for Children’s Hospitals ............................................................
Certifications to Enroll DSH & Children’s Hospitals Outpatient facilities to 340B Program ................................
DSH & Children’s Hospitals’ Annual Recertification ........
70
1
70
.25
17.5
80
1
80
.25
20
180
937
1
1
180
937
.083
.5
14.94
468.5
Registration for Entities Other Than Hospitals & Recertifications
340B Registration Form (Family Planning, STD, TB,
and others) ...................................................................
Family Planning Annual Recertification ...........................
STD & TB Annual Recertification ....................................
Other Entity Annual Recertification for entities other
than DSHs, FP, STD or TB entities .............................
Submission of Administrative Changes for any entity .....
170
85
111
1
47
11
170
3995
1221
.083
.083
.083
14.11
331.59
101.34
400
460
10
1
4000
460
.083
.083
332
38.18
.083
..........................
166
1504.16
Contracted Pharmacy Services Registration & Recertifications
Contracted Pharmacy Services Registration ...................
Total ..........................................................................
2000
* 4493
1
........................
2000
13,313
* The total number of respondents may be overestimated since we are unable to avoid duplication of respondents who submit information to
the OPA over the course of participation in the 340B Drug Pricing Program, via the initial registration process to any updates/modifications and
enrolling contract pharmacies, if applicable, to the recertification process.
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov
or by fax to 202–395–6974. Please direct
all correspondence to the ‘‘attention of
the desk officer for HRSA.’’
Dated: August 5, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E9–19381 Filed 8–12–09; 8:45 am]
erowe on DSK5CLS3C1PROD with NOTICES
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Health
Promotion and Disease Prevention
Research Centers, Special Interest
Project Competitive Supplements
(SIPS) (U48 Panels N, O and P), RFA–
DP09–101SUPP09, Initial Review
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Dates:
9 a.m.–5 p.m., August 5, 2009 (closed).
9 a.m.–5 p.m., August 6, 2009 (closed).
9 a.m.–5 p.m., August 7, 2009 (closed).
Place: Westin Hotel, 3377 Peachtree Road,
NE., Atlanta, GA, 30326, Telephone (678)
500–3100.
Status: The meeting will be closed to the
public in accordance with provisions set
VerDate Nov<24>2008
15:29 Aug 12, 2009
Jkt 217001
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of the application received in
response to ‘‘Health Promotion and Disease
Prevention Research Centers, Special Interest
Project Competitive Supplements (SIPS) (U48
Panels N, O and P), RFA–DP09–101SUPP09,
initial review.’’
Contact Person for More Information:
Brenda Colley-Gilbert, Ph.D., Director,
Extramural Research Program Office, CCH,
47770 Buford Highway, MS K–92, Atlanta,
GA 30341, Telephone (770) 488–8390.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–19293 Filed 8–12–09; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\13AUN1.SGM
13AUN1
]]>Agencies
[Federal Register Volume 74, Number 155 (Thursday, August 13, 2009)]
[Notices]
[Page 40822]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19293]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Health Promotion and Disease Prevention Research
Centers, Special Interest Project Competitive Supplements (SIPS) (U48
Panels N, O and P), RFA-DP09-101SUPP09, Initial Review
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Dates:
9 a.m.-5 p.m., August 5, 2009 (closed).
9 a.m.-5 p.m., August 6, 2009 (closed).
9 a.m.-5 p.m., August 7, 2009 (closed).
Place: Westin Hotel, 3377 Peachtree Road, NE., Atlanta, GA,
30326, Telephone (678) 500-3100.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of the application received in response
to ``Health Promotion and Disease Prevention Research Centers,
Special Interest Project Competitive Supplements (SIPS) (U48 Panels
N, O and P), RFA-DP09-101SUPP09, initial review.''
Contact Person for More Information: Brenda Colley-Gilbert,
Ph.D., Director, Extramural Research Program Office, CCH, 47770
Buford Highway, MS K-92, Atlanta, GA 30341, Telephone (770) 488-
8390.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-19293 Filed 8-12-09; 8:45 am]
BILLING CODE 4163-18-P
